Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"NPMc+"”.

  1. Investigating the translational and metabolic reprogramming of the bone marrow niche in myeloid malignancy

    … AML driven by MLL-AF9 or FLT3-ITD;NPMc mutations, we show that AML protein synthesis levels increase at relapse dependently on nestin+ BMSCs. Inhibiting cap-dependent translation in BMSCs abolishes their chemoprotective ability, whereas BMSCs and their EVs rescue cap-dependent …

    cambridge Repository record for Investigating the translational and metabolic reprogramming of the bone marrow niche in myeloid malignancy (opens in a new tab)

  2. Improving best practice guidelines for Xylazine-related wounds : a DNP project

    … and implemented in a nonprofit mobile clinic (NPMC) in southeastern Michigan. Patients identified as "at-risk" were provided with one-on-one education sessions, and healthcare providers received training on the new guidelines. Results: Implementing the screening tool and wound care guidelines …

    msu Repository record for Improving best practice guidelines for Xylazine-related wounds : a DNP project (opens in a new tab)

  3. Non-precious metal catalysts prepared by chemical functionalization of carbon surfaces.

    … the discovery of non-precious metal catalysts (NPMC) with activity comparable to that of Pt. The Fe-N/C catalyst system is a promising alternative, though the exact structure of the active catalytic site is still debated. Active catalysts are typically formed by high temperature (600 – 1000°C) …

    uoit Repository record for Non-precious metal catalysts prepared by chemical functionalization of carbon surfaces. (opens in a new tab)

  4. THE METHIONINE CYCLE AS A NOVEL THERAPEUTIC TARGET IN NPM1C DRIVEN ACUTE MYELOID LEUKEMIA

    Acute myeloid leukemia (AML) is the most common leukemia in adults and its prognosis is usually poor. Patients are still treated with conventional chemotherapy, which induces disease cure in <40% of patients. The main culprit of therapy failure is the genomic and biological heterogeneity of the …

    milano Repository record for THE METHIONINE CYCLE AS A NOVEL THERAPEUTIC TARGET IN NPM1C DRIVEN ACUTE MYELOID LEUKEMIA (opens in a new tab)